Protons 101
Subscribe
Sign in
Home
Notes
Archive
About
Latest
Top
Discussions
PSA Screening: Data Speaks Loudly
Recommendations changed in 2012 and outcomes immediately worsened. What the data shows and how we can do better.
Jun 8
•
Mark Storey MD
6
Share this post
Protons 101
PSA Screening: Data Speaks Loudly
Copy link
Facebook
Email
Notes
More
9
May 2025
IMRT De-escalation vs: Protons
How should we consider these two approaches?
May 18
•
Mark Storey MD
4
Share this post
Protons 101
IMRT De-escalation vs: Protons
Copy link
Facebook
Email
Notes
More
2
Head and Neck Cancer: Elective Nodal De-Escalation
A New Era in elective nodal dosing is replacing a 60+ year standard.
May 4
•
Mark Storey MD
10
Share this post
Protons 101
Head and Neck Cancer: Elective Nodal De-Escalation
Copy link
Facebook
Email
Notes
More
2
May 2024
Protons vs. Photons: Esophageal Cancer
In Part 2 of this series, we'll look at the data for esophageal cancer
May 12, 2024
•
Mark Storey MD
1
Share this post
Protons 101
Protons vs. Photons: Esophageal Cancer
Copy link
Facebook
Email
Notes
More
Protons vs. Photons: Lung Cancer
A look at data for where toxicities might differ between the two modalities
May 5, 2024
•
Mark Storey MD
2
Share this post
Protons 101
Protons vs. Photons: Lung Cancer
Copy link
Facebook
Email
Notes
More
2
April 2024
Translating Non-Uniform RBE Modeling to the Clinic
A Concept... this time explained in more depth.
Apr 3, 2024
•
Mark Storey MD
1
Share this post
Protons 101
Translating Non-Uniform RBE Modeling to the Clinic
Copy link
Facebook
Email
Notes
More
3
March 2024
Translating New RBE Modeling to the Clinic
A Concept...
Mar 24, 2024
•
Mark Storey MD
Share this post
Protons 101
Translating New RBE Modeling to the Clinic
Copy link
Facebook
Email
Notes
More
5
IMRT is the de facto standard of care for the treatment of definitive disease
Prior authorization denials for IMRT in definitive cancer treatment cases should be an embarrassment to everyone in cancer care.
Mar 10, 2024
•
Mark Storey MD
9
Share this post
Protons 101
IMRT is the de facto standard of care for the treatment of definitive disease
Copy link
Facebook
Email
Notes
More
February 2024
Proton Therapy for Lung Cancer
In a search for better...
Feb 25, 2024
•
Mark Storey MD
3
Share this post
Protons 101
Proton Therapy for Lung Cancer
Copy link
Facebook
Email
Notes
More
The Opportunity in High Risk Prostate Cancer: De-escalation of ADT.
Our data is old creating opportunity.
Feb 11, 2024
•
Mark Storey MD
9
Share this post
Protons 101
The Opportunity in High Risk Prostate Cancer: De-escalation of ADT.
Copy link
Facebook
Email
Notes
More
13
January 2024
Market trends: A Rebuttal
A recent article made my blood boil. We'll look deeper and see if my gut was right or wrong.
Jan 28, 2024
•
Mark Storey MD
2
Share this post
Protons 101
Market trends: A Rebuttal
Copy link
Facebook
Email
Notes
More
2
Sunset Trial: Pushing Dose in Lung Cancer
How quickly and high can we go in Ultra-Central Disease?
Jan 14, 2024
•
Mark Storey MD
6
Share this post
Protons 101
Sunset Trial: Pushing Dose in Lung Cancer
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
